TB-500 5 mg

TB-500 5mg – product details

TB-500 5mg is a synthetic research peptide described in the literature as N-terminally acetylated fragment 17-23 of thymosin beta-4, identified by the sequence Ac-LKKTETQ. From a structural perspective, this molecule represents a short functional fragment associated with the actin-binding domain, which forms the basis for its classification as a peptide analysed in studies of cytoskeletal organisation, cell migration and tissue response to injury.

In the scientific literature TB-500 5mg is described primarily in relation to the wider biological background beta-4 thymosins, which plays an important role in regulating actin dynamics, cell movement and tissue remodelling. Studies indicate that the active domain-associated fragment of the LKKTETQ was analysed in the context of cell migration, angiogenesis and repair processes, making the TB-500 5mg has become a focus of interest in soft tissue reconstruction and cellular adaptation models.

Also check out the peptide reagent TB-500 10 mg 

An important area of scientific interest also remains the relationship between activity TB-500 5mg and processes related to healing and the tissue regenerative environment. In publications on beta-4 thymosins the association of this group of peptides with accelerating wound healing, promoting angiogenesis and promoting the migration of cells involved in the repair of damaged structures has been described. It is the combination of studies on actin, cell movement and repair processes that provides the main basis for the interest in this molecule in experimental analyses of regeneration.

From a scientific characterisation perspective, the following are among the main research strengths TB-500 5 mg includes small molecule size, linkage to well-described biology beta-4 thymosins and the presence of literature analysing the fragment 17-23 as an important functional element of this group of peptides. At the same time, the interpretation of the results should take into account that much of the data relates to the full beta-4 thymosins, and not just the commercially described TB-500, Therefore, the description of this substance should remain cautious and clearly investigative.

Scientific sources:

1. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500 - identification TB-500 as a fragment of Ac-LKKTETQ.
2. Biological activities of thymosin beta4 defined by active sites in short peptide sequences - domain description LKKTETQ and its relationship to angiogenesis, healing and cell migration.
3. Thymosin β4: a multi-functional regenerative peptide - broad overview of regenerative functions Tβ4.
4. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development - data on angiogenesis and tissue healing.

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.